Clinical Trial Update: Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating interferon-γ in combination with donor leukocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndromes af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Interferon (interferon)

Snippet

Sponsor: Sawa Ito, MD | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: RECRUITING